ClinicalTrials.Veeva

Menu
K

Keystone Research | Austin, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Bimatoprost
Netarsudil
K-321
Axitinib
K-161
Phenylephrine
AR-15512
Ripasudil
VVN461

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 16 total trials

Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.

This is a randomized, double-blind, two-treatment, single-period, parallel design, multiple dose at multiple clinical trial sites designed to demonst...

Enrolling
Ocular Hypertension
Glaucoma, Open-Angle
Drug: Test - Bimatoprost 0.01% Ophthalmic Solution
Drug: Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution)

This study will evaluate the long-term safety and efficacy of Bimatoprost Sustained Release (SR) in patients with open-angle glaucoma or ocular hyper...

Invitation-only
Open-Angle Glaucoma
Ocular Hypertension
Drug: Bimatoprost SR
Other: Standard of Care

The goal of this clinical trial is to test the safety and efficacy of an ocular medication on the treatment of pterygium.

Active, not recruiting
Pterygium
Drug: RMP-A03 - Dose 1
Drug: RMP-A03 - Dose 2

Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (axitinib implant) in Subjects with Neovascular Age-Related Macular Degeneration

Enrolling
Neovascular Age-Related Macular Degeneration
Drug: OTX-TKI (axitinib implant)
Drug: Aflibercept

Trial sponsors

Aerie Pharmaceuticals logo
AbbVie logo
Allergan logo
Kowa logo
Alcon logo
A
E
Glaukos logo
Ocular Therapeutix logo
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems